Article Type
Changed
Mon, 04/01/2019 - 12:48
Display Headline
Abciximab prevents ischemic complications during angioplasty
The EPILOG Trial
Article PDF
Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Issue
Cleveland Clinic Journal of Medicine - 65(5)
Publications
Page Number
267-272
Sections
Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Author and Disclosure Information

Matthew T. Roe, MD
Department of Cardiology, Cleveland Clinic

David J. Moliterno, MD
Department of Cardiology, Cleveland Clinic; medical director, angiographic core laboratory, EPILOG trial

Address: David J. Moliterno, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195

Article PDF
Article PDF
The EPILOG Trial
The EPILOG Trial
Issue
Cleveland Clinic Journal of Medicine - 65(5)
Issue
Cleveland Clinic Journal of Medicine - 65(5)
Page Number
267-272
Page Number
267-272
Publications
Publications
Article Type
Display Headline
Abciximab prevents ischemic complications during angioplasty
Display Headline
Abciximab prevents ischemic complications during angioplasty
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Article PDF Media